Renal cell carcinoma (RCC) represents the sixth most frequently diagnosed cancer in men
and is asymptomatic, being detected mostly incidentally. The apparition of symptoms …

The advent of Surface-Enhanced Raman Scattering (SERS) has enabled the exploration
and detection of small molecules, particularly in biological fluids such as serum, blood …

Surface-enhanced Raman scattering (SERS) is used for the differentiation of human kidney
adenocarcinoma, human kidney carcinoma, and non-cancerous human kidney embryonic …

In this study, we mainly aimed to investigate the diagnostic potential of surface-enhanced
Raman spectroscopy for bladder cancer and kidney cancer which are the most common …

Renal cancer (RC) represents 3% of all cancers, with a 2% annual increase in incidence
worldwide, opening the discussion about the need for screening. However, no established …

Detecting cancers through testing biological fluids, namely,“liquid biopsy”, is noninvasive
and shows great promise in cancer diagnosis, surveillance and screening. Many …

The detection of kidney cancers at an early stage is critical for diagnosis and therapy.
Surface-enhanced Raman scattering (SERS) is investigated for early detection of cancer …

Aim: Previous studies regarding surface-enhanced Raman scattering (SERS) of serum have
shown promising initial results in discriminating prostate cancer, a strategy which could …

This study aims to classify low-grade and high-grade bladder cancer (BC) patients using
serum surface-enhanced Raman scattering (SERS) spectra and support vector machine …

This study aims to characterize and classify serum surface-enhanced Raman spectroscopy
(SERS) spectra between bladder cancer patients and normal volunteers by genetic …